Search

Search Results

• CUTANEOUS HYPERPIGMENTATION IN MEGALOBLASTIC ANEMIA: A FIVE YEAR RETROSPECTIVE REVIEW.

  Somanath Padhi, RajLaxmi Sarangi, Anita Ramdas, Kandasamy Ravichandran, Renu G’Boy Varghese, Thomas Alexander, George Kurien, Sudhagar Mookkappan

  e2016021

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.021

  4474

  PDF: 994

  HTML: 12696

• THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.

  Sagir Gumel Ahmed

  e2011028

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.028

  5099

  PDF: 1310

  HTML: 2734

  Cover letter: 187

• The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma

  Sujith V Cherian, Subhraleena Das, Bandita Das Basu, Robert E Hutchison

  e2013019

  2013-02-20

  https://doi.org/10.4084/mjhid.2013.019

  1742

  PDF: 680

  HTML: 2397

  Untitled: 145

  Figure 1 a: 151

  Figure 1 b: 161

  Fig 1 c: 143

  Figure 1 d: 189

• Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report.

  John Ayodele Olaniyi

  e2011008

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.008

  2273

  PDF: 571

  HTML: 1158

• ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

  Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko

  e2018014

  2018-02-15

  https://doi.org/10.4084/mjhid.2018.014

  5214

  PDF: 1903

  HTML: 1340

• MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

  Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan

  e2015001

  2015-01-01

  https://doi.org/10.4084/mjhid.2015.001

  2252

  PDF: 1316

  HTML: 17067

  Bassan Fig.1: 138

  Bassan Fig.2: 145

  Bassan Fig.4: 133

  Fig.3: 177

• DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY

  Dibyendu De, Uttam Kumar Nath

  e2015028

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.028

  2355

  PDF: 1098

  HTML: 2160

  Untitled: 156

• THE TREATMENT OF ADVANCED-STAGE MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A HEMATOLOGIST'S POINT OF VIEW.

  Antonio Giordano, Livio Pagano

  e2022029

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.029

  2018

  PDF: 1012

  HTML: 256

• Multiple bone and joint disease in a sickle cell anaemia patient: a case report

  John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari

  e2012023

  2012-05-03

  https://doi.org/10.4084/mjhid.2012.023

  1230

  PDF: 723

  HTML: 1705

• CLINICOPATHOLOGICAL PROFILE OF SALMONELLA TYPHI AND PARATYPHI INFECTIONS PRESENTING AS FEVER OF UNKNOWN ORIGIN IN A TROPICAL COUNTRY.

  Nayyar Iqbal, Aneesh Basheer, Sudhagar Mookkappan, Anita Ramdas, Renu G'Boy Varghese, Somanath Padhi, Bhairappa Shrimanth, Saranya Chidambaram, Anandhalakshmi S, Reba Kanungo

  e2015021

  2015-02-17

  https://doi.org/10.4084/mjhid.2015.021

  3931

  PDF: 1072

  HTML: 4690

• CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA

  Alessandro Bartoloni, Lorenzo Zammarchi

  e2012026

  2012-05-04

  https://doi.org/10.4084/mjhid.2012.026

  7810

  PDF: 4065

  HTML: 7322

• ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

  Alessandro Busca, Livio Pagano

  e2016039

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.039

  4684

  PDF: 1539

  HTML: 2241

  Untitled: 200

  Untitled: 217

  Untitled: 224

  Untitled: 208

  Untitled: 208

• Hemophagocytic lymphohistiocytosis: an unusual complication in Orientia tsutsugamushi disease (scrub typhus).

  Aneesh Basheer, Somanath Padhi, Vinoth Boopathy, Saumyaranjan Mallick, Shashikala Nair, Renu G'Boy Varghese, Reba Kanungo

  e2015008

  2014-12-23

  https://doi.org/10.4084/mjhid.2015.008

  3991

  PDF: 1528

  HTML: 4329

• BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

  Roberto Castelli

  e2016030

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.030

  4311

  PDF: 971

  HTML: 1657

• A CASE SERIES HIGHLIGHTING THE RELATIVE FREQUENCY OF COMMON, UNCOMMON AND ATYPICAL/UNUSUAL HEMATOLOGICAL FINDINGS ON BONE MARROW EXAMINATION IN CASES OF VISCERAL LEISHMANIASIS

  Prateek Bhatia, Dipanjan Haldar, Neelam Varma, RK Marwaha, Subhash Varma

  e2011035

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.035

  1344

  PDF: 600

  HTML: 3456

  Figures Leismania: 166

• COMPARATIVE EVALUATION OF BONE MARROW ASPIRATE WITH TREPHINE BIOPSY IN HEMATOLOGICAL DISORDERS AND DETERMINATION OF OPTIMUM TREPHINE LENGTH IN LYMPHOMA INFILTRATION

  Surbhi Goyal, Usha Rani Singh, Usha Rusia

  e2014002

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.002

  1897

  PDF: 1047

  HTML: 51774

• CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

  Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone

  e2024010

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.010

  3959

  PDF: 3264

  HTML: 190

• SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

  Massimo Breccia, Giuliana Alimena

  e2014003

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.003

  3087

  PDF: 1201

  HTML: 3461

• BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

  Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

  e2016011

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.011

  4274

  PDF: 1467

  HTML: 3605

• GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey

  Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN

  e2023031

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.031

  1327

  PDF: 891

  Suppl. Files: 448

  HTML: 222